Handelsbanken Fonder AB Acquires 81,200 Shares of Avantor, Inc. $AVTR

Posted by George Bondi on Aug 17th, 2026

Handelsbanken Fonder AB grew its holdings in Avantor, Inc. (NYSE:AVTR – Free Report) by 41.2% during the 2nd quarter, Holdings Channel.com reports. The fund owned 278,500 shares of the company’s stock after acquiring an additional 81,200 shares during the period. Handelsbanken Fonder AB’s holdings in Avantor were worth $2,757,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its position in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares in the last quarter. Private Trust Co. NA lifted its holdings in Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor in the 2nd quarter worth approximately $32,000. Los Angeles Capital Management LLC bought a new position in Avantor in the 4th quarter worth approximately $32,000. Finally, Osaic Holdings Inc. boosted its stake in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the period. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Shares of NYSE:AVTR opened at $13.65 on Monday. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The stock has a market capitalization of $9.24 billion, a P/E ratio of -16.26, a PEG ratio of 10.29 and a beta of 0.89. The firm has a fifty day simple moving average of $11.21 and a two-hundred day simple moving average of $9.54. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR – Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. The firm had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.24 EPS. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, analysts expect that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AVTR has been the topic of several recent analyst reports. Sanford C. Bernstein assumed coverage on shares of Avantor in a research report on Friday, June 26th. They set a “market perform” rating and a $10.50 price objective on the stock. Barclays lifted their target price on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, June 24th. Morgan Stanley boosted their target price on Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Stifel Nicolaus increased their price target on Avantor from $8.00 to $15.00 and gave the company a “hold” rating in a research note on Thursday, July 30th. Finally, Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. Two equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $12.00.

Check Out Our Latest Report on AVTR

Avantor Company Profile

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.